Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule.
Real time oxidative stress in the extracellular compartment of rat striatum was characterized by microdialysis with synthetic non-dialyzable marker molecules composed of linoleic acid, tyrosine and guanosine (N-linoleoyl tyrosine (LT) and N-linoleoyl tyrosine 2'-deoxyguanosyl ester (LTG)). Partial dopaminergic deafferentation was induced by injection of 6-hydroxydopamine (250 microg) to the left lateral ventricle, which depleted ipsilateral striatal dopamine by 46% and dopaminergic cells in left substantia nigra by 44%, 5 weeks after administration. Resting microdialysate dopamine levels in dopamine-depleted striatum were not different from sham-operated rats, although the ratio of oxidized metabolites of dopamine to free dopamine was significantly increased. Hydroperoxide and epoxy products of the linoleoyl portion of LT and LTG were detected in the striatal microdialysate by LC/MS/MS following initial separation by HPLC and were significantly increased in dopamine-depleted compared with control striatum without an increase in guanosine or tyrosine oxidation or nitration. Systemic administration of N-acetyl cysteine (350 mg/kg i.p.) decreased the increment in hydroperoxide and epoxy metabolites to levels not significantly different from control. Oxidation activity towards polyunsaturated fatty acids is present in the extracellular space of partially dopamine-denervated striatum, whereas oxidized glutathione and oxysterol levels in striatal tissue are decreased, possibly indicative of a compensatory response.
Aluf
Y
Y
Laboratory of Natural Medicinal Compounds, Migal-Galilee Technology Center, and Tel Hai College, Kiryat Shmona, Israel.
Vaya
J
J
Khatib
S
S
Loboda
Y
Y
Kizhner
S
S
Finberg
John P M
JP
D018663:Adrenergic Agents / Q000633:toxicity; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D002853:Chromatography, Liquid; D003342:Corpus Striatum / Q000378:metabolism*; D003849:Deoxyguanosine / Q000031:analogs & derivatives*; D004298:Dopamine / Q000378:metabolism; D005609:Free Radicals / Q000032:analysis*; D007150:Immunohistochemistry; D019787:Linoleic Acid; D008041:Linoleic Acids; D008297:Male; D017551:Microdialysis / Q000379:methods*; D018384:Oxidative Stress / Q000502:physiology*; D016627:Oxidopamine / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D053719:Tandem Mass Spectrometry
D018663:Adrenergic Agents; D005609:Free Radicals; D008041:Linoleic Acids; C521388:linoleoyl tyrosine 2-deoxyguanosyl ester; D016627:Oxidopamine; D019787:Linoleic Acid; D003849:Deoxyguanosine; D004298:Dopamine